MICHELLE GUADAGNO: Open Payments
NPI 1760883839 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 8 payments from 7 companies in 2025. Trend: 2023 $535 · 2024 $91 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $248 |
| Adaptive Biotechnologies Corporation | 1 | $130 |
| SANOFI-AVENTIS U.S. LLC | 1 | $96 |
| Boston Scientific Corporation | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $24 |
| Iovance Biotherapeutics, Inc. | 1 | $23 |
| Arteriocyte Medical Systems, Inc. | 1 | $21 |
Products named: clonoSEQ, VENCLEXTA, EPKINLY, REZUROCK, WaveWriter Alpha Prime 16, Orserdu, Amtagvi, Magellan.
Industry payments across NC — which companies pay providers there.
